Isofol receives notice that Clinical Use Patent in Europe for Drug Candidate arfolitixorin will be approved ...Middle East

GOTHENBURG, Sweden, March 22, 2021 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today announced that a notice that a Clinical Use Patent for the drug candidate arfolitixorin will be approved in Europe. The patent covers a dose regimen for...

Hence then, the article about isofol receives notice that clinical use patent in europe for drug candidate arfolitixorin will be approved was published today ( Monday 22/03/2021 - 01:46 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Isofol receives notice that Clinical Use Patent in Europe for Drug Candidate arfolitixorin will be approved )

Also on site :

• Wind Advisory issued April 17 at 2:56AM PDT until April 17 at 8:00AM PDT by NWS Los Angeles/Oxnard CA
• Inside The ‘Landmark’ Exhibition Showcasing The Story of Black British Music at London’s Brand-New V&A
• Manycore, the first of the Hangzhou ‘Little Dragons’ to go public, pushes ‘spatial intelligence’ as the next wave of AI development